Mortality in adults with sickle cell disease and pulmonary hypertension
about
Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemiaGroup 5 Pulmonary Hypertension: The Orphan's Orphan Disease.The global burden of pulmonary hypertension in sickle cell disease: a systematic review and meta-analysis.Pulmonary complications of sickle cell disease.Computed tomography correlates with cardiopulmonary hemodynamics in pulmonary hypertension in adults with sickle cell disease.Cellular, pharmacological, and biophysical evaluation of explanted lungs from a patient with sickle cell disease and severe pulmonary arterial hypertensionRisk factors for death in 632 patients with sickle cell disease in the United States and United KingdomPulmonary hypertension: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.Heme-bound iron activates placenta growth factor in erythroid cells via erythroid Krüppel-like factorMicroRNA 648 Targets ET-1 mRNA and is cotranscriptionally regulated with MICAL3 by PAX5.Mechanistic insights and characterization of sickle cell disease-associated cardiomyopathyVasculopathy and pulmonary hypertension in sickle cell disease.Sickle cell disease and venous thromboembolism: what the anticoagulation expert needs to knowThe role of phosphodiesterase inhibitors in the management of pulmonary vascular diseasesBiological parameters predictive of percent dense red blood cell decrease under hydroxyurea.Doppler-Defined Pulmonary Hypertension in Sickle Cell Anemia in Kurdistan, Iraq.A novel molecular signature for elevated tricuspid regurgitation velocity in sickle cell disease.Long-term outcome and evaluation of organ function in pediatric patients undergoing haploidentical and matched related hematopoietic cell transplantation for sickle cell disease.Pathophysiology and treatment of pulmonary hypertension in sickle cell diseaseParadoxical protection from atherosclerosis and thrombosis in a mouse model of sickle cell disease.Reduced sensitivity of the ferroportin Q248H mutant to physiological concentrations of hepcidinHemodynamic predictors of mortality in adults with sickle cell diseaseLongitudinal study of echocardiography-derived tricuspid regurgitant jet velocity in sickle cell diseaseSildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertensionSleep-disordered breathing and nocturnal hypoxemia in young adults with sickle cell disease.Sickle cell anemia mice develop a unique cardiomyopathy with restrictive physiology.Review: Hemodynamic Characteristics and Outcomes of Sickle Cell Disease Associated Pulmonary Hypertension.Pulmonary vascular and ventricular dysfunction in the susceptible patient (2015 Grover Conference series).Pulmonary hypertension associated with chronic hemolytic anemia and other blood disorders.Differences in the clinical and genotypic presentation of sickle cell disease around the world.Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease.[Evaluation of hemogram in patients with homozygous sickle cell disease: about 87 cases].An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease.Sickle cell disease: time for a closer look at treatment options?Update in pulmonary vascular diseases 2012.Pathophysiology and principles of management of the many faces of the acute vaso-occlusive crisis in patients with sickle cell disease.Chronic Pulmonary Complications of Sickle Cell Disease.Minireview: Genetic basis of heterogeneity and severity in sickle cell disease.Genetics of Sickle Cell-Associated Cardiovascular Disease: An Expert Review with Lessons Learned in Africa.Hematological disorders and pulmonary hypertension.
P2860
Q28395387-10DD8F21-D2B6-4546-A545-566F1449DF2AQ30248872-E35D3B3D-2879-41CA-8250-A3D0E66E8B13Q30250302-D7AD5973-F72C-41F3-8ECE-2005A43C4724Q30515769-5B7DCF85-0207-417C-A444-80DAE1B12E76Q33805998-54CF6CED-A819-4E01-B005-C813A5831696Q33806253-3DD54198-E7A7-44CC-BCA7-F97754598391Q33837174-0981A59F-17F6-45B5-8A5D-C6E4D0753694Q33956819-636D56B2-5EFB-4BED-8E0F-687AB6AF05C2Q34019609-7ECE7C72-33D2-4B75-8C35-1D7A5012DB15Q34846466-B2B4F9D2-3EAA-4918-8EAD-6383D741A8B9Q35078958-56F986EC-658D-4421-96B6-2B9C9D4491B9Q35086394-F211A4E7-0604-4C3E-95F0-5A60D2FDD817Q35105431-B07C9CAB-94E6-42CF-9B3D-3C28111533A4Q35156618-2DE66EDC-A918-413D-8BE7-A561EA6587F7Q35604335-09080E32-BB5B-49A8-92B8-385B92420E33Q36119758-B2D912F6-190A-4AEE-9C38-7FA089D47834Q36238248-64743C0A-96ED-4C6B-BB31-A4817D9A00D1Q36461789-3990F862-0DE0-4BFB-9C0C-49565F117211Q36596861-1A9EB1F1-9E60-4080-84C8-691CB8ADC992Q36657988-B87FDA5F-42E9-4FBD-82F7-443173080B08Q36862359-DDA9F44B-D624-4846-A588-A93FF3C52948Q36999803-07F14CEC-D3A5-4296-909C-ECDE8A59BA07Q37138218-5437D9EF-0BD6-403B-B630-5897C568AB22Q37144856-EB4466A3-02C8-4B10-A3CC-1ED3B53A3B32Q37196718-57887120-4D63-4E20-9BA9-35275C953287Q37258558-37FDF1DF-0C70-4868-ADC2-69E4FC417616Q37354098-A36F3D37-8B30-4008-B317-D18FCB448971Q37555431-15A34DB4-0AA4-4636-8E3C-A0BE2076DFCDQ37565002-0F7BFFEA-4C94-4DB2-A1DE-5C0304258529Q37620798-E2B42594-9B35-48A8-AF0A-D131977CEA5EQ37636986-8AEB8BC6-C492-47AF-B081-9A054069136BQ37680845-98F38A94-8190-4B88-BCAF-E94CA35F84BAQ37698249-FBCB8EDD-45EF-4012-999B-F10C5BCECCADQ38114921-E848FBD6-7AF7-40AF-B506-1572A599C79AQ38118390-340BA570-5C0B-4764-8376-09ACC58C1BB8Q38257400-8B2785D3-B77F-4CEC-9C4F-A954D684BA2CQ38719970-C794E926-2BF3-41F1-95F5-77E82BD1B9C1Q38758451-9C704B73-849D-4CED-B74C-5E7296FB5696Q38977617-974469C1-C2C9-4000-889B-03773F6FB06CQ39077582-345C0773-CC42-4116-989D-2CD8FB65316C
P2860
Mortality in adults with sickle cell disease and pulmonary hypertension
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Mortality in adults with sickle cell disease and pulmonary hypertension
@ast
Mortality in adults with sickle cell disease and pulmonary hypertension
@en
type
label
Mortality in adults with sickle cell disease and pulmonary hypertension
@ast
Mortality in adults with sickle cell disease and pulmonary hypertension
@en
prefLabel
Mortality in adults with sickle cell disease and pulmonary hypertension
@ast
Mortality in adults with sickle cell disease and pulmonary hypertension
@en
P2093
P2860
P356
P1476
Mortality in adults with sickle cell disease and pulmonary hypertension
@en
P2093
Alem Mehari
Roberto F Machado
P2860
P304
P356
10.1001/JAMA.2012.358
P407
P577
2012-03-01T00:00:00Z